Jingming Jia

Prof. Jingming Jia


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
XLXuanli Liu
Xuanli Liu
GHGaosheng Hu
Gaosheng Hu
AWAn-Hua Wang
An-Hua Wang
GLGuoqing Long
Guoqing Long
YYYongcheng Yang
Yongcheng Yang
JJJingming Jia
Jingming Jia
Black tea was reported to alter the microbiome populations and metabolites in diet-induced obese mice and displays properties that prevent obesity, but the underlying mechanism of the preventative effect of black tea on high-fat diet (HFD) induced obesity has not been elucidated. Epigenetic studies are a useful tool for determining the relationship between obesity and environment. Here, we show that the water extract of black tea (Lapsang souchong, LS) reverses HFD-induced gut dysbiosis, alters the tissue gene expression, changes the level of a major epigenetic modification (DNA methylation), and prevents obesity in HFD feeding mice. The anti-obesity properties of black tea are due to alkaloids, which are the principal active components. Our data indicate that the anti-obesity benefits of black tea are transmitted via fecal transplantation, and the change of tissue gene expression and the preventative effects on HFD-induced obesity in mice of black tea are dependent on the gut microbiota. We further show that black tea could regulate the DNA methylation of imprinted genes in the spermatozoa of high-fat diet mice. Our results show a mechanistic link between black tea, changes in the gut microbiota, epigenetic processes, and tissue gene expression in the modulation of diet-induced metabolic dysfunction.

1 July 2025 in Microbiology Spectrum
Verified
Journal Article
Open access
XSXianduo Sun
Xianduo Sun
GHGaosheng Hu
Gaosheng Hu
YLYuting Li
Yuting Li
WLWenjing Li
Wenjing Li
YWYong Wang
Yong Wang
JJJingming Jia
Jingming Jia
Gut microbiota have been found to promote hypoxia-induced intestinal injury. However, the role of gut microbiota in high-altitude pulmonary edema (HAPE), the preventive effect of synbiotic on HAPE, and the mechanisms by which they might work remain unknown. In this study, we aimed to investigate the role of gut microbiota in the pathogenesis of HAPE and to explore the underlying mechanisms involved. We performed a fecal microbiome analysis and found a significant decrease in intestinal Klebsiella and Escherichia-Shigella , along with a notable increase in intestinal Bifidobacterium and Lactobacillus , as volunteers recovered from acute mountain sickness (AMS). Gavage colonization with Klebsiella pneumoniae and Escherichia coli induced plasma inflammation, increased plasma lysophosphatidylcholine (LPC) levels, and contributed to HAPE in rats at a simulated altitude of 6,500 m. Conversely, a synbiotic containing Bifidobacterium , Lactiplantibacillus , fructooligosaccharides, and isomaltose-oligosaccharides significantly reduced the severity of HAPE. Cellular experiments and molecular dynamics simulations revealed that LPCs can cause damage and permeability to human pulmonary microvascular endothelial cell (HPMEC) and human pulmonary alveolar epithelial cell (HPAEpiC) monolayers under hypoxic conditions by disrupting cell membrane integrity. In addition, tail vein injection of LPCs promoted HAPE in mice at a simulated altitude of 6,500 m. In conclusion, this study describes a gut microbiota-LPCs/inflammation-HAPE axis, an important new insight into HAPE that will help open avenues for prevention and treatment approaches. IMPORTANCE: The role of the gut microbiota in high-altitude pulmonary edema (HAPE) is currently unknown. This study found that intestinal Klebsiella pneumoniae and Escherichia coli contribute to HAPE by inducing inflammation and increasing lysophosphatidylcholine (LPC) levels under hypoxic conditions. Conversely, a synbiotic containing Bifidobacterium , Lactiplantibacillus , fructooligosaccharides, and isomaltose-oligosaccharides significantly reduced the severity of HAPE. Further investigation revealed that LPCs can cause damage and permeability to human pulmonary microvascular endothelial cell (HPMEC) and human pulmonary alveolar epithelial cell (HPAEpiC) monolayers under hypoxic conditions by disrupting cell membrane integrity. These findings contribute to the understanding of the pathogenesis of HAPE and will benefit populations living at high altitude or traveling from low to high altitude.

6 October 2022 in Natural Product Research
Verified
Journal Article
Closed access
KWKun-Jun Wang
Kun-Jun Wang
TBTe-Ri-Gen Bao
Te-Ri-Gen Bao
YYYong-Cheng Yang
Yong-Cheng Yang
DWDong-Dong Wang
Dong-Dong Wang
AWAn-Hua Wang
An-Hua Wang
JJJingming Jia
Jingming Jia
A new biflavone (philonotisflavone-3′′′-methyl ether), three diterpenes (lupulin G, lupulin H, lupulin I), a new ecdysteroid (ajugasterone E), and four known compounds were isolated from the whole plant of Ajuga lupulina Maxim. Their structures were determined by spectroscopic analysis, including MS, NMR and ECD spectral data. Compounds 1-3 has DPPH radical scavenging ability, and compound 1 has stronger activity than vitamin C. Compounds 2, 3, 7 and 8 have potential cytotoxic activity against Hela, with IC50 values less than 20.0 μM. Abietane diterpenes 2, 3, 7 and 8 are also found to have NO inhibitory effects with IC50 values less than 40.0 μM. Graphical Abstract

16 March 2023 in Natural Product Research
Verified
Journal Article
Closed access
JXJianwei Xie
Jianwei Xie
KWKunjun Wang
Kunjun Wang
XGXiaoxu Gao
Xiaoxu Gao
AWAnhua Wang
Anhua Wang
GHGaosheng Hu
Gaosheng Hu
JJJingming Jia
Jingming Jia
Two undescribed polyacetylated 18-norspirostanol saponins, trilliumosides J (1) and 21-deoxyepitrillenoside C (2), a novel resveratrol aneuploid, 3a,3b-dimethoxyhopeachinol B (3) along with four known steroidal saponins (4–7), were isolated from the 70% EtOH extract of the roots and rhizomes of Trillium camschatcense. The structures of isolated compounds were elucidated by spectroscopic analysis and chemical degradation. Compounds 1,3 and 4 had potential cytotoxic activity against MCF-7, with IC50 values 86.38 ± 2.59 μM, 56.20 ± 1.57 μM and 45.70 ± 0.63 μM. Graphical Abstract

29 October 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
WLWenjing Li
Wenjing Li
XSXianduo Sun
Xianduo Sun
YZYazhao Zhang
Yazhao Zhang
YLYanan Li
Yanan Li
ZCZhikang Chen
Zhikang Chen
JJJingming Jia
Jingming Jia
The gut microbiota dysbiosis is a key factor leading to inflammatory bowel disease (IBD). Darutigenol (DL) is a natural compound with limited oral bioavailability but potent anti-inflammatory activity. However, its ameliorative efficacy in colitis and precise mechanism remain unexplored. This study demonstrated through multi-omics analysis and fecal microbiota transplantation (FMT) experiments that the alleviation of colitis in male mice by DL is dependent on the gut microbiota. Mechanistically, DL specifically enriches the abundance of Akkermansia muciniphila (A. muciniphila), which alleviates colitis by promoting the synthesis of proline. Interestingly, DL was found to promote the growth of A. muciniphila in the gut by targeting indoleamine 2,3-dioxygenase 1 (IDO1). Additionally, exogenous proline supplementation alleviated murine colitis by downregulating the IL-17 signaling pathway and its downstream cascades. Our findings reveal that DL ameliorates colitis by inhibiting IDO1 expression to drive A. muciniphila expansion and proline synthesis, and highlights the potential of DL for the treatment of IBD.